New application of a pentapeptide and its metabolites in the preparation of anti-dementia products
A metabolite and dementia technology, applied in the field of medicine and reagent technology, can solve the problems of small peptides and their metabolite anti-dementia product reports that have not yet been discovered, and achieve significant advantages of brain permeability, small molecular weight, and easy blood-brain barrier Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
preparation example Construction
[0168] As for the preparation methods of small peptides used to prepare anti-dementia products, they are all mature methods, which have been published in various journals and patent documents, and will not be repeated in the present invention.
[0169] In the present invention, the specific implementation manners described above and the examples described below are for better illustrating the present invention, and are not used to limit the scope of the invention.
Embodiment 1
[0172] Embodiment 1, the preparation of small peptide
[0173] ① The amino acid sequence of the pentapeptide MLIF is shown in SEQ ID NO: 1: Met-Gln-Cys-Asn-Ser.
[0174] ② The amino acid sequence of the tetrapeptide QS is shown in SEQ ID NO: 2: Gln-Cys-Asn-Ser.
[0175] ③ The amino acid sequence of the tetrapeptide MN is shown in SEQ ID NO: 3: Met-Gln-Cys-Asn.
[0176] ④ The amino acid sequence of the tripeptide CS is shown in SEQ ID NO: 4: Cys-Asn-Ser.
[0177] ⑤ The amino acid sequence of the tripeptide MC is shown in SEQ ID NO: 5: Met-Gln-Cys.
[0178] ⑥ The amino acid sequence of the dipeptide MQ is shown in SEQ ID NO: 6: Met-Gln
[0179] ⑦ The amino acid sequence of the dipeptide NS is shown in SEQ ID NO: 7: Asn-Ser.
[0180] The above small peptides were synthesized by Guangdong Bajiayi Pharmaceutical Co., Ltd., with a purity of more than 98%.
Embodiment 2
[0181] Embodiment 2, to the protective effect of the vascular dementia rat model that middle cerebral artery embolization method makes
[0182] 2.1 Establishment of vascular dementia rat model produced by middle cerebral artery embolization method Rats were treated with 10% chloral hydrate 350mg·kg -1 Intraperitoneal injection of anesthesia, median neck incision, separation and ligation of the proximal end of the right common carotid artery, external carotid artery and its branch arteries. The right internal carotid artery was separated, the pterygognathic artery was separated downward along the internal carotid artery, and the root of the branch was ligated. An incision was made at the bifurcation of the common carotid artery, and a nylon thread was inserted to a depth of 17-20mm. The thread was tied into the internal carotid artery, and then into the cranium to the anterior cerebral artery, blocking all sources of blood flow in the middle cerebral artery. After 2 hours of i...
PUM
Property | Measurement | Unit |
---|---|---|
diameter | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com